SCHEMBL4837871

SCHEMBL4837871

CC(C)(C)OC(=O)c1ccc(NCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3cc(C(F)(F)F)ccc3Cl)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
RORC P51449 4/20 0.38
MMP8 P22894 4/20 0.36
MMP3 P08254 2/20 0.36
IL2 P60568 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
MITF O75030 1/20 0.35
GNRHR P30968 2/20 0.35
ALOX5 P09917 1/20 0.35
MAPK1 P28482 1/20 0.34
GAA P10253 2/20 0.34
PKM P14618 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841575 0.94 MAPT (0.39) MAPTRORCMMP8MMP3IL2
SCHEMBL4834001 0.91 ALOX5 (0.41) MAPTRORCMMP8MMP3IL2
SCHEMBL4833426 0.91 FFAR4 (0.40) MAPTRORCMMP8MMP3FFAR4
SCHEMBL4840697 0.87 CRHR1 (0.41) MAPTRORCMMP8MMP3IL2
SCHEMBL4837354 0.86 MAPT (0.39) MAPTRORCMMP8MMP3IL2
SCHEMBL4837997 0.82 FFAR4 (0.43) RORCMMP8MMP3FFAR4ALOX5
SCHEMBL4832552 0.82 FFAR4 (0.44) MAPTRORCMMP8MMP3FFAR4
SCHEMBL4842938 0.81 ALOX5 (0.41) MAPTRORCMMP8MMP3FFAR4
SCHEMBL4842917 0.81 FFAR4 (0.41) MAPTRORCMMP8MMP3FFAR4
SCHEMBL4842178 0.80 PTGER3 (0.37) MAPTRORCMMP8MMP3IL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MAPT 763/4885RORC 1777/4885MMP8 3968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.